Stock-Based Compensation | 5. Stock-Based Compensation Equity Incentive Plans On January 27, 2012, the Company approved the 2011 Equity Incentive Plan (the “2011 Plan”). The 2011 Plan authorized the Company to issue options to employees, consultants and directors exercisable for up to a total of 3,750,000 shares of common stock. As of September 25, 2021, all awards granted by the Company under the 2011 Plan have been nonqualified stock options. Options granted under the 2011 Plan have a life of 10 years and vest over service periods of five years or in connection with certain events as defined by the 2011 Plan. On October 19, 2014, the Company approved the 2014 Equity Incentive Plan, which was amended as of August 24, 2016 (as amended, the “2014 Plan”). Following the approval of the 2014 Plan, no further grants have been made under the 2011 Plan. The 2014 Plan authorizes the Company to issue awards to employees, consultants and directors for up to a total of 3,600,000 shares of common stock. As of September 25, 2021, all awards granted by the Company under the 2014 Plan to date have been nonqualified stock options, restricted stock awards, restricted stock units or performance share units. Options granted under the 2014 Plan have a life of eight four one one four On August 26, 2020, the Company approved the 2020 Equity Incentive Plan (the “2020 Plan”). Following the approval of the 2020 Plan, no further grants have been made under the 2014 Plan. The 2020 Plan authorizes the Company to issue awards to employees and directors for up to a total of 2,000,000 shares of common stock. As of September 25, 2021, all awards granted by the Company under the 2020 Plan to date have been restricted stock units or performance share units. Restricted stock units vest over service periods of one Non-Qualified Stock Options During the thirteen weeks ended September 25, 2021, the Company did not grant options to purchase shares. During the thirteen weeks ended September 26, 2020, the Company granted certain members of management options to purchase a total of 22,838 shares under the 2014 Plan. The total grant date fair value of stock options granted during the thirteen weeks ended September 26, 2020 was $0.3 million, with grant date fair values of $12.71 per share. Subject to certain exceptions, the Company is recognizing the expense relating to these stock options on a straight-line basis over the four-year service period of the awards. The exercise price of these awards is $23.57 per share. During the twenty-six weeks ended September 25, 2021, the company did not grant options to purchase shares. During the twenty-six weeks ended September 26, 2020, the Company granted certain members of management options to purchase a total of 287,373 shares under the 2014 Plan. The total grant date fair value of stock options granted during the twenty-six weeks ended September 26, 2020 was $3.1 million, with grant date fair values of $10.40 to $12.71 per share. Subject to certain exceptions, the Company is recognizing the expense relating to these stock options on a straight-line basis over the four-year service period of the awards. The exercise price of these awards ranges from $20.94 to $24.08 per share. Thirteen Weeks Ended Twenty-Six Weeks Ended September 25, September 26, September 25, September 26, 2021 2020 2021 2020 Expected option term (1) N/A 6.3 years N/A 6.3 years Expected volatility factor (2) N/A 58.4 % N/A 57.0 % - 58.4 % Risk-free interest rate (3) N/A 0.3 % N/A 0.30 % - 0.4 % Expected annual dividend yield N/A 0 % N/A 0 % (1) The Company has limited historical information regarding expected option term. Accordingly, the Company determined the expected life of the options using the simplified method. (2) Stock volatility for each grant is measured using the weighted average of historical daily price changes of the Company’s stock and its competitors’ common stock over the most recent period equal to the expected option term of the Company’s awards. (3) The risk-free interest rate is determined using the rate on treasury securities with the same term. Intrinsic value for stock options is defined as the difference between the market price of the Company’s common stock on the last business day of the fiscal quarter and the weighted average exercise price of in-the-money stock options outstanding at the end of each fiscal period. The following table summarizes the stock award activity for the twenty-six weeks ended September 25, 2021: Grant Date Weighted Weighted Average Aggregate Stock Average Remaining Intrinsic Options Exercise Price Contractual Life Value (in years) (in thousands) Outstanding at March 27, 2021 1,111,919 $ 20.94 Granted — $ — Exercised (281,513) $ 16.13 $ 17,784 Cancelled, forfeited or expired (7,703) $ 21.73 Outstanding at September 25, 2021 822,703 $ 22.58 6.8 $ 60,471 Vested and expected to vest after September 25, 2021 822,703 $ 22.58 6.8 $ 60,471 Exercisable at September 25, 2021 163,995 $ 17.87 5.1 $ 12,826 A summary of the status of non-vested stock options as of September 25, 2021 including changes during the twenty-six weeks ended September 25, 2021 is presented below: Weighted- Average Grant Date Shares Fair Value Nonvested at March 27, 2021 952,929 $ 8.36 Granted — $ — Vested (286,518) $ 6.78 Nonvested shares forfeited (7,703) $ 9.51 Nonvested at September 25, 2021 658,708 $ 9.04 Restricted Stock Units During the thirteen weeks ended September 25, 2021, the Company granted 4,433 restricted stock units to various employees under the 2020 Plan. The shares granted vest in four During the twenty-six weeks ended September 25, 2021, the Company granted 64,275 restricted stock units to various directors and employees under the 2020 Plan. The shares granted to employees vest in four first During the thirteen weeks ended September 26, 2020, the Company granted 8,066 restricted stock units to various employees under the 2014 Plan. The shares granted to employees vest in four first During the twenty-six weeks ended September 26, 2020, the Company granted 175,527 restricted stock units to various directors and employees under the 2014 Plan. The shares granted to employees vest in four installments beginning on the grant date, provided that the respective award recipient continues to be employed by the Company through each of those dates (subject to certain exceptions). The shares granted to the Company’s directors vest on the first Performance Share Units During the thirteen weeks ended September 25, 2021, the Company did not grant any performance share units. During the twenty-six weeks ended September 25, 2021, the company granted During the thirteen and twenty-six weeks ended September 26, 2020, the Company did not grant any performance share units. The performance share units granted during the twenty-six weeks ended September 25, 2021 are stock-based awards in which the number of shares ultimately received depends on the Company's performance against its cumulative earnings per share target over a three-year performance period beginning March 28, 2021 and ending March 30, 2024. These performance metrics were established by the Company at the beginning of the performance period. At the end of the performance period, the number of performance shares to be issued is fixed based upon the degree of achievement of the performance goals. If the cumulative three-year performance goals are below the threshold level, the number of performance units to vest will be 0%, if the performance goals are at the threshold level, the number of performance units to vest will be 50% of the target amounts, if the performance goals are at the target level, the number of performance units to vest will be 100% of the target amounts, and if the performance goals are at the maximum level, the number of performance units to vest will be 200% of the target amounts, each subject to continued service through the last day of the performance period (subject to certain exceptions). If performance is between threshold and target goals or between target and maximum goals, the number of performance units to vest will be determined by linear interpolation. The number of shares ultimately issued can range from 0% to 200% of the participant's target award. The grant date fair value of the performance share units granted during the twenty-six weeks ended September 25, 2021 was initially measured using the Company's closing stock price on the date of grant with the resulting stock compensation expense recognized on a straight-line basis over the three-year vesting period, subject to certain exceptions. The expense recognized over the vesting period is adjusted up or down on a quarterly basis based on the anticipated performance level during the performance period. If the performance metrics are not probable of achievement during the performance period, stock compensation expense would be reversed. The awards are forfeited if the threshold performance goals are not achieved as of the end of the performance period. Stock-Based Compensation Expense Stock-based compensation expense was $2.8 million and $1.7 million for the thirteen weeks ended September 25, 2021 and September 26, 2020, respectively. Stock-based compensation expense was $6.0 million and $3.5 million for the twenty-six weeks ended September 25, 2021 and September 26, 2020, respectively. Stock-based compensation expense of $0.3 million and $0.2 million was recorded in cost of goods sold in the condensed consolidated statements of operations for the thirteen weeks ended September 25, 2021 and September 26, 2020, respectively. Stock-based compensation expense of $1.0 million and $0.8 million was recorded in cost of goods sold in the condensed consolidated statements of operations for the twenty-six weeks ended September 25, 2021 and September 26, 2020, respectively. All other stock-based compensation expense is included in selling, general and administrative expenses in the condensed consolidated statements of operations. As of September 25, 2021, there was $3.2 million of total unrecognized stock-based compensation expense related to unvested stock options, with a weighted-average remaining recognition period of 1.92 years. As of September 25, 2021, there was $6.2 million of total unrecognized stock-based compensation expense related to restricted stock units, with a weighted-average remaining recognition period of 2.71 years. As of September 25, 2021, there was $3.4 million of total unrecognized stock-based compensation expense related to performance share units, with a weighted-average remaining recognition period of 2.36 years. |